Hiroko Mori

2.4k total citations
121 papers, 1.9k citations indexed

About

Hiroko Mori is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Hiroko Mori has authored 121 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 22 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Genetics. Recurrent topics in Hiroko Mori's work include Parathyroid Disorders and Treatments (12 papers), Diabetes Management and Research (9 papers) and Diabetes Treatment and Management (9 papers). Hiroko Mori is often cited by papers focused on Parathyroid Disorders and Treatments (12 papers), Diabetes Management and Research (9 papers) and Diabetes Treatment and Management (9 papers). Hiroko Mori collaborates with scholars based in Japan, United States and India. Hiroko Mori's co-authors include Yosuke Okada, Yoshiya Tanaka, Keiichi Torimoto, Mitsuhiro Kawata, Tadashi Arao, Ken Matsuda, Toshiyuki Arai, J. William Carey, Zhou Lei and Hari Viswanathan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Radiology.

In The Last Decade

Hiroko Mori

117 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Mori Japan 21 520 476 278 220 170 121 1.9k
Yoshiaki Kondo Japan 25 249 0.5× 1.2k 2.6× 110 0.4× 236 1.1× 135 0.8× 115 2.2k
Koji Yamamoto Japan 23 189 0.4× 755 1.6× 180 0.6× 233 1.1× 264 1.6× 104 2.4k
Robert S. Hoover United States 24 410 0.8× 1.1k 2.3× 54 0.2× 160 0.7× 206 1.2× 48 2.0k
Yafeng Wang China 24 132 0.3× 634 1.3× 114 0.4× 176 0.8× 261 1.5× 156 2.3k
Kazuyuki Kitamura Japan 19 221 0.4× 322 0.7× 45 0.2× 189 0.9× 161 0.9× 68 1.3k
Jianbo Zhou China 23 226 0.4× 322 0.7× 109 0.4× 108 0.5× 274 1.6× 80 1.4k
Yasuhiro Shibata Japan 25 347 0.7× 779 1.6× 156 0.6× 174 0.8× 305 1.8× 163 2.4k
Takashi Yoneda Japan 28 1.5k 2.9× 625 1.3× 125 0.4× 913 4.2× 349 2.1× 159 2.7k
Bellamkonda Kishore United States 31 230 0.4× 2.0k 4.3× 161 0.6× 304 1.4× 364 2.1× 86 3.3k
Yoshihiro Nishi Japan 33 579 1.1× 1.1k 2.3× 671 2.4× 254 1.2× 573 3.4× 110 3.8k

Countries citing papers authored by Hiroko Mori

Since Specialization
Citations

This map shows the geographic impact of Hiroko Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Mori more than expected).

Fields of papers citing papers by Hiroko Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Mori. The network helps show where Hiroko Mori may publish in the future.

Co-authorship network of co-authors of Hiroko Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Mori. A scholar is included among the top collaborators of Hiroko Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Mori. Hiroko Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujikawa, Hirohisa, Daisuke Son, Hiroko Mori, et al.. (2023). Development and assessment of a vaccine administration training course for medical students. BMC Medical Education. 23(1). 385–385. 3 indexed citations
2.
3.
4.
Mori, Hiroko, et al.. (2016). A Case of Type 2 Diabetes with a Change from a Non-Dipper to a Dipper Blood Pressure Pattern by Dapagliflozin. Journal of UOEH. 38(2). 149–153. 11 indexed citations
5.
Mori, Hiroko, Ken‐ichi Matsuda, Masanaga Yamawaki, & Mitsuhiro Kawata. (2014). Estrogenic Regulation of Histamine Receptor Subtype H1 Expression in the Ventromedial Nucleus of the Hypothalamus in Female Rats. PLoS ONE. 9(5). e96232–e96232. 7 indexed citations
6.
7.
8.
Torimoto, Keiichi, Yosuke Okada, Hiroko Mori, et al.. (2013). Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes. Lipids in Health and Disease. 12(1). 137–137. 40 indexed citations
9.
Mori, Hiroko, Yosuke Okada, & Yoshiya Tanaka. (2012). [Diabetes mellitus and osteoporosis. Mutual interaction between bone and blood vessel in diabetes mellitus].. PubMed. 22(9). 1343–51. 2 indexed citations
10.
Mori, Hiroko, Yosuke Okada, Yoshiya Tanaka, & Osamu Hashimoto. (2012). [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].. PubMed. 22(7). 1034–42. 1 indexed citations
11.
Okada, Yosuke, et al.. (2012). Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide. Internal Medicine. 51(17). 2375–2378. 24 indexed citations
12.
Mori, Hiroko, Yosuke Okada, Kunihiro Yamaoka, Kazuyoshi Saito, & Yoshiya Tanaka. (2011). Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. Journal of Bone and Mineral Metabolism. 30(1). 114–118. 15 indexed citations
13.
Okada, Yosuke, Hiroko Mori, Yoshiya Tanaka, & Osamu Hashimoto. (2010). [Positioning of bisphosphonates for vascular calcification].. PubMed. 20(11). 1711–7. 1 indexed citations
14.
Arai, Toshiyuki, Keisuke Makino, Nobuyuki Endo, et al.. (2007). The Radical Scavenger Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one) Reacts with a Pterin Derivative and Produces a Cytotoxic Substance That Induces Intracellular Reactive Oxygen Species Generation and Cell Death. Journal of Pharmacology and Experimental Therapeutics. 324(2). 529–538. 16 indexed citations
15.
Arai, Toshiyuki, Hiroko Yamada, Tsunehisa Namba, et al.. (2004). Effects of intracellular reactive oxygen species generated by 6-formylpterin on T cell functions. Biochemical Pharmacology. 67(6). 1185–1193. 13 indexed citations
16.
Fukui, Michiaki, Koji Nakano, Hiroshi Obayashi, et al.. (1997). High prevalence of mitochondrial diabetes mellitus in Japanese patients with major risk factors. Metabolism. 46(7). 793–795. 13 indexed citations
17.
Abe, Hiroshi, et al.. (1996). [Effect of ulinastatin on delayed neuronal death in the gerbil hippocampus].. PubMed. 45(1). 38–43. 12 indexed citations
18.
Fukuda, Teruo, Naofumi Matsunaga, Koki Nakanishi, et al.. (1991). [Computed tomographic features in ovarian bleeding].. PubMed. 51(4). 394–9. 1 indexed citations
19.
Yamanoi, Akira, et al.. (1984). Alterations in the Levels of β-Endorphin-Like Immunoreactivity in Plasma and Tissues of Obese Rats with Hypothalamic Lesions. Hormone and Metabolic Research. 16(2). 105–106. 14 indexed citations
20.
Mori, Hiroko, et al.. (1975). ON INFANTILE PAPULAR ACRODERMATITIS (GIANOTTI DISEASE) AND INFANTILE PAPULAR‐SIMILVESICULAR ACRODERMATITIS (GIANOTTI SYNDROME). The Journal of Dermatology. 2(1). 5–14. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiaki Kondo Breakdown of academic impact, for papers by Koji Yamamoto Breakdown of academic impact, for papers by Robert S. Hoover Breakdown of academic impact, for papers by Yafeng Wang Breakdown of academic impact, for papers by Kazuyuki Kitamura Breakdown of academic impact, for papers by Jianbo Zhou Breakdown of academic impact, for papers by Yasuhiro Shibata Breakdown of academic impact, for papers by Takashi Yoneda Breakdown of academic impact, for papers by Bellamkonda Kishore Breakdown of academic impact, for papers by Yoshihiro Nishi
Rankless by CCL
2026